Latest & greatest articles for hypertension

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hypertension or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hypertension and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hypertension

161. Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous

Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous 28979751 2018 11 13 2008-5842 9 8 2017 Aug Electronic physician Electron Physician Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous. 5122-5128 10.19082/5122 Pulmonary arterial hypertension (PAH) is (...) as a valuable marker for early diagnosis of asymptomatic pulmonary hypertension in patients with SLE. Ghofraniha Leila L Pulmonologist, Lung Disease Research Center, School of Medicine, Mashhad University of Medicine Sciences, Mashhad, Iran. Mirfeizi Zahra Z MD, Associate Professor of Rheumatology, Rheumatic Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Khabbaz Fatemeh Seyyedi FS MD, Associate Professor of Rheumatology, Rheumatic Diseases Research

Electronic physician2017 Full Text: Link to full Text with Trip Pro

162. Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease

Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease 28760941 2018 01 29 2018 11 13 1524-4563 70 4 2017 10 Hypertension (Dallas, Tex. : 1979) Hypertension Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. 687-694 10.1161/HYPERTENSIONAHA.117.08314 Griffin Karen A KA From the Hines VA Hospital, IL; and Loyola University Medical Center, Maywood, IL. kgriffi@lumc.edu. eng R01 DK040426 DK NIDDK NIH HHS United States R01 DK061653 DK NIDDK NIH HHS United (...) States Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Review 2017 07 31 United States Hypertension 7906255 0194-911X IM Disease Progression Humans Hypertension complications physiopathology Renal Insufficiency, Chronic etiology physiopathology 2017 8 2 6 0 2018 1 30 6 0 2017 8 2 6 0 ppublish 28760941 HYPERTENSIONAHA.117.08314 10.1161/HYPERTENSIONAHA.117.08314 PMC5599324 NIHMS891429 Curr Opin Nephrol Hypertens. 2012 Jan;21(1):1-6 22048724 Hypertension

Hypertension (Dallas, Tex. : 1979)2017 Full Text: Link to full Text with Trip Pro

163. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study.

Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. Objectives To determine how soon after delivery the risk of post-pregnancy hypertension increases in women with hypertensive disorders of pregnancy and how the risk evolves over time. Design Nationwide register based cohort study. Setting Denmark. Populations 482 972 primiparous women with a first live birth or stillbirth between 1995 and 2012 (cumulative incidence (...) analyses), and 1 025 118 women with at least one live birth or stillbirth between 1978 and 2012 (Cox regression analyses). Main outcome measures 10 year cumulative incidences of post-pregnancy hypertension requiring treatment with prescription drugs, and hazard ratios estimated using Cox regression. Results Of women with a hypertensive disorder of pregnancy in a first pregnancy in their 20s, 14% developed hypertension in the first decade post partum, compared with 4% of women with normotensive first

BMJ2017 Full Text: Link to full Text with Trip Pro

164. Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study.

Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study. Objectives To study the association between lifestyle risk factors and chronic hypertension by history of hypertensive disorders of pregnancy (HDP: gestational hypertension and pre-eclampsia) and investigate the extent to which these risk factors modify the association between HDP and chronic hypertension. Design Prospective cohort study. Setting (...) Nurses' Health Study II (1991-2013). Participants 54 588 parous women aged 32 to 59 years with data on reproductive history and without previous chronic hypertension, stroke, or myocardial infarction. Main outcome measure Chronic hypertension diagnosed by a physician and indicated through nurse participant self report. Multivariable Cox proportional hazards models were used to investigate the development of chronic hypertension contingent on history of HDP and four lifestyle risk factors: post

BMJ2017 Full Text: Link to full Text with Trip Pro

166. Trial of decompressive craniectomy for traumatic intracranial hypertension

Trial of decompressive craniectomy for traumatic intracranial hypertension 29118837 2018 11 13 1751-1437 18 3 2017 Aug Journal of the Intensive Care Society J Intensive Care Soc Trial of decompressive craniectomy for traumatic intracranial hypertension. 236-238 10.1177/1751143716685246 eng Journal Article Review 2017 06 29 England J Intensive Care Soc 101538668 1751-1437 2017 11 10 6 0 2017 11 10 6 0 2017 11 10 6 1 ppublish 29118837 10.1177/1751143716685246 10.1177_1751143716685246 PMC5665128 N

Journal of the Intensive Care Society2017 Full Text: Link to full Text with Trip Pro

167. Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial. BACKGROUND: Between 62 000 and 77 000 women die annually from pre-eclampsia and eclampsia. Prompt delivery, preferably by the vaginal route, is vital for good maternal and neonatal outcomes. Two low-cost interventions-low-dose oral misoprostol tablets and transcervical Foley catheterisation-are already used in low-resource (...) settings. We aimed to compare the relative risks and benefits of these interventions. METHODS: We undertook this multicentre, open-label, randomised controlled trial in two public hospitals in Nagpur, India. Women (aged ≥18 years) who were at 20 weeks' gestation or later with a live fetus and required delivery as a result of pre-eclampsia or hypertension were randomly assigned (1:1), via computer-generated block randomisation (block sizes of four, six, and eight) with concealment by use of opaque

Lancet2017

168. Hypertensive retinopathy as the initial presentation of neuroblastoma

Hypertensive retinopathy as the initial presentation of neuroblastoma 29260095 2018 11 13 2451-9936 7 2017 Sep American journal of ophthalmology case reports Am J Ophthalmol Case Rep Hypertensive retinopathy as the initial presentation of neuroblastoma. 123-125 10.1016/j.ajoc.2017.06.008 To describe a case of a patient who presented with hypertensive retinopathy and was found to have neuroblastoma. Neuroblastoma has three main ocular presentations. As a primary disease, it can present (...) with a paraneoplastic syndrome in the form of opsoclonus, or it can present as a Horner's syndrome from its effect on the cervical sympathetic ganglia. Metastatic disease can present as a triad of periorbital edema, ecchymosis and proptosis from orbital bone involvement. Hypertension is a rare systemic presentation of neuroblastoma. We report the case of a two-year-old girl whose initial presentation of neuroblastoma was hypertensive retinopathy. To our knowledge, this is the first reported case of neuroblastoma

American journal of ophthalmology case reports2017 Full Text: Link to full Text with Trip Pro

169. Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor (VEGF) inhibition

Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor (VEGF) inhibition 28630211 2018 01 29 2018 11 13 1524-4563 70 2 2017 08 Hypertension (Dallas, Tex. : 1979) Hypertension Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition. 220-226 10.1161/HYPERTENSIONAHA.117.08856 Touyz Rhian M RM From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular (...) ., A.H.J.D.). eng K08 HL116952 HL NHLBI NIH HHS United States RG/13/7/30099 British Heart Foundation United Kingdom RE/13/530177 British Heart Foundation United Kingdom Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review 2017 06 19 United States Hypertension 7906255 0194-911X 0 Antihypertensive Agents 0 Vascular Endothelial Growth Factor A EC 2.7.10.1 Receptors, Vascular Endothelial Growth Factor IM Antihypertensive Agents pharmacology therapeutic use Humans

Hypertension (Dallas, Tex. : 1979)2017 Full Text: Link to full Text with Trip Pro

170. Mammalian Glutamyl Aminopeptidase Genes (ENPEP) and Proteins: Comparative Studies of a Major Contributor to Arterial Hypertension

Mammalian Glutamyl Aminopeptidase Genes (ENPEP) and Proteins: Comparative Studies of a Major Contributor to Arterial Hypertension 29900035 2018 11 14 2153-0602 8 2 2017 Journal of data mining in genomics & proteomics J Data Mining Genomics Proteomics Mammalian Glutamyl Aminopeptidase Genes (ENPEP) and Proteins: Comparative Studies of a Major Contributor to Arterial Hypertension. 2 10.4172/2153-0602.1000211 Glutamyl aminopeptidase (ENPEP) is a member of the M1 family of endopeptidases which (...) 24098452 J Biol Chem. 2013 Sep 6;288(36):26004-12 23897806 J Mol Biol. 2001 Jan 19;305(3):567-80 11152613 Nat Struct Mol Biol. 2011 May;18(5):604-13 21478864 Curr Hypertens Rep. 2016 Apr;18(4):29 26951246 Dev Biol. 2006 Jun 1;294(1):203-19 16574097 Genes Immun. 2014 Dec;15(8):521-7 25142031 Bioinformatics. 2000 Apr;16(4):404-5 10869041 Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7069-73 8346219 Oncotarget. 2017 Mar 28;8(13):21266-21280 28177885 PLoS One. 2014 Jan 22;9(1):e85594 24465611 Hypertension

Journal of data mining in genomics & proteomics2017 Full Text: Link to full Text with Trip Pro

172. Hypertension and diabetes: if chlortalidone is unavailable, an ACE inhibitor should be the drug of choice

Hypertension and diabetes: if chlortalidone is unavailable, an ACE inhibitor should be the drug of choice Prescrire IN ENGLISH - Spotlight ''Hypertension and diabetes: if chlortalidone is unavailable, an ACE inhibitor should be the drug of choice'', 1 June 2017 {1} {1} {1} | | > > > Hypertension and diabetes: if chlortalidone is unavailable, an ACE inhibitor should be the drug of choice Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |    (...) |   |   |   |   |   |   |  Spotlight Hypertension and diabetes: if chlortalidone is unavailable, an ACE inhibitor should be the drug of choice Hypertension treatment in diabetes patients aims to reduce the risk of complications: cardiovascular events, end-stage renal failure, deterioration of eyesight. Patients with diabetes are exposed to arterial damage, including coronary artery disease and stroke, and damage to the blood capillaries

Prescrire2017

173. CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean N

CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean N 28455320 2017 04 29 2017 05 23 1524-4628 48 6 2017 Jun Stroke Stroke CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age (...) 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study. 1524-1530 10.1161/STROKEAHA.117.016926 The CHA2DS2-VASc stroke score (congestive heart failure, hypertension, age ≥75 (doubled), diabetes mellitus, prior stroke or transient ischemic attack (doubled), vascular disease, age 65-74, female) is used in most guidelines for risk stratification in atrial fibrillation (AF), but most data for this score have been derived in Western populations

EvidenceUpdates2017

174. Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction

Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction 28549665 2018 07 05 2018 11 13 1089-8611 69 2017 Sep 30 Nitric oxide : biology and chemistry Nitric Oxide Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction. 78-90 S1089-8603(16)30280-4 10.1016/j.niox.2017.05.005 Aerobic exercise training (...) is an effective therapy to improve peak aerobic power (peak VO 2 ) in individuals with hypertension (HTN, AHA/ACC class A) and heart failure patients with preserved ejection fraction (HFpEF). High nitrate containing beetroot juice (BRJ) also improves sub-maximal endurance and decreases blood pressure in both HTN and HFpEF. We hypothesized that combining an aerobic exercise and dietary nitrate intervention would result in additive or even synergistic positive effects on exercise tolerance and blood

Nitric oxide : biology and chemistry2017 Full Text: Link to full Text with Trip Pro

175. Resistant Hypertension: An Update of Experimental and Clinical Findings

Resistant Hypertension: An Update of Experimental and Clinical Findings 28507173 2018 01 29 2018 11 13 1524-4563 70 1 2017 07 Hypertension (Dallas, Tex. : 1979) Hypertension Resistant Hypertension: An Update of Experimental and Clinical Findings. 5-9 10.1161/HYPERTENSIONAHA.117.08929 Cai Anping A From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham (A.C., D.A.C.); and Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key (...) Laboratory of Coronary Heart Disease Prevention, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (A.C.). acai@uabmc.edu. Calhoun David A DA From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham (A.C., D.A.C.); and Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (A.C

Hypertension (Dallas, Tex. : 1979)2017 Full Text: Link to full Text with Trip Pro

176. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study.

Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. Objective To determine the role of early onset versus late onset hypertension as a risk factor for hypertension in offspring and cardiovascular death. Design Multigenerational, prospective cohort study. Setting Framingham Heart Study. Participants Two generations of community dwelling participants with blood pressure measurements performed at serial (...) examinations spanning six decades: 3614 first generation participants with mortality data and 1635 initially non-hypertensive second generation participants with data available on parental blood pressure. Main outcome measures The main outcome measures were relation of parental early onset hypertension (age <55 years) with incidence of hypertension in offspring, using regression analyses, and relation of age at hypertension onset with cause specific mortality using a case (cardiovascular death) versus

BMJ2017 Full Text: Link to full Text with Trip Pro

177. The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study.

The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. Objective To prospectively examine the relation between the Dietary Approaches to Stop Hypertension (DASH) and Western diets and risk of gout (ie, the clinical endpoint of hyperuricemia) in men. Design Prospective cohort study. Setting The Health Professionals Follow-up Study. Participants 44 444 men with no history of gout at baseline. Using validated food frequency (...) for gout, adjusting for potential confounders, including age, body mass index, hypertension, diuretic use, and alcohol intake. Results During 26 years of follow-up, 1731 confirmed cases of incident gout were documented. A higher DASH dietary pattern score was associated with a lower risk for gout (adjusted relative risk for extreme fifths 0.68, 95% confidence interval 0.57 to 0.80, P value for trend <0.001). In contrast, a higher Western dietary pattern score was associated with an increased risk

BMJ2017 Full Text: Link to full Text with Trip Pro

178. Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension

Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension 29201764 2018 11 13 2231-5047 7 1 2017 Jan-Jun Euroasian journal of hepato-gastroenterology Euroasian J Hepatogastroenterol Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension. 6-10 10.5005/jp-journals-10018-1203 To investigate whether mean platelet volume (MPV) is a predictor of variceal bleeding in patients with cirrhotic portal hypertension. This (...) , Danalioglu A, Kayhan B. Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension. Euroasian J Hepato-Gastroenterol 2017;7(1):6-10. A Erdogan Mehmet M Department of Gastroenterology, Karabük Education and Research Hospital, Karabük University, Karabük, Turkey. R Benli Ali A Department of Family Medicine, Karabük University, Karabük, Turkey. B Acmali Serap S Department of Family Medicine, Dudullu Aile Sağliği Merkezleri, Istanbul Turkey. Koroglu Mustafa M

Euroasian journal of hepato-gastroenterology2017 Full Text: Link to full Text with Trip Pro

179. Continuous subcutaneous treprostinil for treatment of pulmonary arterial hypertension

Continuous subcutaneous treprostinil for treatment of pulmonary arterial hypertension Continuous subcutaneous treprostinil for treatment of pulmonary arterial hypertension Continuous subcutaneous treprostinil for treatment of pulmonary arterial hypertension HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Continuous subcutaneous (...) treprostinil for treatment of pulmonary arterial hypertension. Lansdale: HAYES, Inc. Healthcare Technology Brief Publication. 2017 Authors' conclusions Pulmonary arterial hypertension (PAH) refers to the vascular remodeling of the small pulmonary arteries that is associated with elevated pulmonary arterial pressure (PAP) and eventually right ventricular failure (RVF). Symptoms of PAH begin as shortness of breath at exertion, later progressing to dyspnea with normal activities, and ultimately dyspnea

Health Technology Assessment (HTA) Database.2017

180. Macitentan (pulmonary arterial hypertension) - Benefit assessment according to õ35a Social Code Book V

Macitentan (pulmonary arterial hypertension) - Benefit assessment according to õ35a Social Code Book V Macitentan (pulmonal arterielle Hypertonie): Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung; Auftrag A16-67 [Macitentan (pulmonary arterial hypertension) - Benefit assessment according to §35a Social Code Book V] Macitentan (pulmonal arterielle Hypertonie): Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung; Auftrag A16-67 [Macitentan (pulmonary arterial hypertension) - Benefit (...) . [Macitentan (pulmonary arterial hypertension) - Benefit assessment according to §35a Social Code Book V] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 476. 2017 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Pyrimidines; Sulfonamides Language Published German Country of organisation Germany English summary There is no English language summary

Health Technology Assessment (HTA) Database.2017